CHAPTER 9: BIOBANKING MARKET, BY REGION
9.1. Overview
9.1.1. Market size and forecast
9.2. North America
9.2.1. Key market trends, growth factors, and opportunities
9.2.2. North America market size and forecast, by country
9.2.2.1. U.S. biobanking market size and forecast, by specimen type
9.2.2.2. U.S. biobanking market size and forecast, by type of biobank
9.2.2.3. U.S. biobanking market size and forecast, by ownership
9.2.2.4. U.S. biobanking market size and forecast, by application
9.2.2.5. US biobanking market size and forecast, by End User
9.2.2.6. Canada biobanking market size and forecast, by specimen type
9.2.2.7. Canada biobanking market size and forecast, by type of biobank
9.2.2.8. Canada biobanking market size and forecast, by ownership
9.2.2.9. Canada biobanking market size and forecast, by application
9.2.2.10. Canada biobanking market size and forecast, by End User
9.2.2.11. Mexico biobanking market size and forecast, by specimen type
9.2.2.12. Mexico biobanking market size and forecast, by type of biobank
9.2.2.13. Mexico biobanking market size and forecast, by ownership
9.2.2.14. Mexico biobanking market size and forecast, by application
9.2.2.15. Mexico biobanking market size and forecast, by End User
9.2.3. North America market size and forecast, by specimen type
9.2.4. North America market size and forecast, by type of biobank
9.2.5. North America biobanking market size and forecast, by ownership
9.2.6. North America biobanking market size and forecast, by application
9.2.7. North America biobanking market size and forecast, by End User
9.3. Europe
9.3.1. Key market trends, growth factors, and opportunities
9.3.2. Europe market size and forecast, by country
9.3.2.1. Germany biobanking market size and forecast, by specimen type
9.3.2.2. Germany biobanking market size and forecast, by type of biobank
9.3.2.3. Germany biobanking market size and forecast, by ownership
9.3.2.4. Germany biobanking market size and forecast, by application
9.3.2.5. Germany biobanking market size and forecast, by End User
9.3.2.6. France biobanking market size and forecast, by specimen type
9.3.2.7. France biobanking market size and forecast, by type of biobank
9.3.2.8. France biobanking market size and forecast, by ownership
9.3.2.9. France biobanking market size and forecast, by application
9.3.2.10. France biobanking market size and forecast, by End User
9.3.2.11. UK biobanking market size and forecast, by specimen type
9.3.2.12. UK biobanking market size and forecast, by type of biobank
9.3.2.13. UK biobanking market size and forecast, by ownership
9.3.2.14. UK biobanking market size and forecast, by application
9.3.2.15. UK biobanking market size and forecast, by End User
9.3.2.16. Italy biobanking market size and forecast, by specimen type
9.3.2.17. Italy biobanking market size and forecast, by type of biobank
9.3.2.18. Italy biobanking market size and forecast, by ownership
9.3.2.19. Italy biobanking market size and forecast, by application
9.3.2.20. Italy biobanking market size and forecast, by End User
9.3.2.21. Spain biobanking market size and forecast, by specimen type
9.3.2.22. Spain biobanking market size and forecast, by type of biobank
9.3.2.23. Spain biobanking market size and forecast, by ownership
9.3.2.24. Spain biobanking market size and forecast, by application
9.3.2.25. Spain biobanking market size and forecast, by End User
9.3.2.26. Rest of Europe biobanking market size and forecast, by specimen type
9.3.2.27. Rest of Europe biobanking market size and forecast, by type of biobank
9.3.2.28. Rest of Europe biobanking market size and forecast, by ownership
9.3.2.29. Rest of Europe biobanking market size and forecast, by application
9.3.2.30. Rest of Europe biobanking market size and forecast, by End User
9.3.3. Europe market size and forecast, by specimen type
9.3.4. Europe market size and forecast, by type of biobank
9.3.5. Europe biobanking market size and forecast, by ownership
9.3.6. Europe biobanking market size and forecast, by application
9.3.7. Europe biobanking market size and forecast, by End User
9.4. Asia-Pacific
9.4.1. Key market trends, growth factors, and opportunities
9.4.2. Asia-Pacific market size and forecast, by country
9.4.2.1. Japan biobanking market size and forecast, by specimen type
9.4.2.2. Japan biobanking market size and forecast, by type of biobank
9.4.2.3. Japan biobanking market size and forecast, by ownership
9.4.2.4. Japan biobanking market size and forecast, by application
9.4.2.5. Japan biobanking market size and forecast, by End User
9.4.2.6. China biobanking market size and forecast, by specimen type
9.4.2.7. China biobanking market size and forecast, by type of biobank
9.4.2.8. China biobanking market size and forecast, by ownership
9.4.2.9. China biobanking market size and forecast, by application
9.4.2.10. China biobanking market size and forecast, by End User
9.4.2.11. India biobanking market size and forecast, by specimen type
9.4.2.12. India biobanking market size and forecast, by type of biobank
9.4.2.13. India biobanking market size and forecast, by ownership
9.4.2.14. India biobanking market size and forecast, by application
9.4.2.15. India biobanking market size and forecast, by End User
9.4.2.16. Australia biobanking market size and forecast, by specimen type
9.4.2.17. Australia biobanking market size and forecast, by type of biobank
9.4.2.18. Australia biobanking market size and forecast, by ownership
9.4.2.19. Australia biobanking market size and forecast, by application
9.4.2.20. Australia biobanking market size and forecast, by End User
9.4.2.21. Rest of Asia-Pacific biobanking market size and forecast, by specimen type
9.4.2.22. Rest of Asia-Pacific biobanking market size and forecast, by type of biobank
9.4.2.23. Rest of Asia-Pacific biobanking market size and forecast, by ownership
9.4.2.24. Rest of Asia-Pacific biobanking market size and forecast, by application
9.4.2.25. Rest of Asia-Pacific biobanking market size and forecast, by End User
9.4.3. Asia-Pacific market size and forecast, by specimen type
9.4.4. Asia-Pacific market size and forecast, by type of biobank
9.4.5. Asia-Pacific biobanking market size and forecast, by ownership
9.4.6. Asia-Pacific biobanking market size and forecast, by application
9.4.7. Asia-Pacific biobanking market size and forecast, by End User
9.5. LAMEA
9.5.1. Key market trends, growth factors, and opportunities
9.5.2. LAMEA market size and forecast, by country
9.5.2.1. Brazil biobanking market size and forecast, by specimen type
9.5.2.2. Brazil biobanking market size and forecast, by type of biobank
9.5.2.3. Brazil biobanking market size and forecast, by ownership
9.5.2.4. Brazil biobanking market size and forecast, by application
9.5.2.5. Brazil biobanking market size and forecast, by End User
9.5.2.6. Saudi Arabia biobanking market size and forecast, by specimen type
9.5.2.7. Saudi Arabia biobanking market size and forecast, by type of biobank
9.5.2.8. Saudi Arabia biobanking market size and forecast, by ownership
9.5.2.9. Saudi Arabia biobanking market size and forecast, by application
9.5.2.10. Saudi Arabia biobanking market size and forecast, by End User
9.5.2.11. South Africa biobanking market size and forecast, by specimen type
9.5.2.12. South Africa biobanking market size and forecast, by type of biobank
9.5.2.13. South Africa biobanking market size and forecast, by ownership
9.5.2.14. South Africa biobanking market size and forecast, by application
9.5.2.15. South Africa biobanking market size and forecast, by End User
9.5.2.16. Rest of LAMEA biobanking market size and forecast, by specimen type
9.5.2.17. Rest of LAMEA biobanking market size and forecast, by type of biobank
9.5.2.18. Rest of LAMEA biobanking market size and forecast, by ownership
9.5.2.19. Rest of LAMEA biobanking market size and forecast, by application
9.5.2.20. Rest of LAMEA biobanking market size and forecast, by End User
9.5.3. LAMEA market size and forecast, by specimen type
9.5.4. LAMEA market size and forecast, by type of biobank
9.5.5. LAMEA biobanking market size and forecast, by ownership
9.5.6. LAMEA biobanking market size and forecast, by application
9.5.7. LAMEA biobanking market size and forecast, by End User
List of Tables
TABLE 01. LIST OF LARGEST GOVERNMENT REGULATED BIOBANKS ACROSS THE GLOBE
TABLE 02. GLOBAL BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 03. BIOBANKING MARKET REVENUE FOR BLOOD PRODUCTS, BY REGION, 2020–2028($MILLION)
TABLE 04. BIOBANKING MARKET REVENUE FOR SOLID TISSUE, BY REGION, 2020–2028($MILLION)
TABLE 05. BIOBANKING MARKET REVENUE FOR CELL LINES, BY REGION, 2020–2028($MILLION)
TABLE 06. BIOBANKING MARKET REVENUE FOR NUCLEIC ACID SAMPLES, BY REGION, 2020–2028($MILLION)
TABLE 07. BIOBANKING MARKET REVENUE FOR OTHERS, BY REGION, 2020–2028($MILLION)
TABLE 08. BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028($MILLION)
TABLE 09. POPULATION-BASED BIOBANKING MARKET REVENUE, BY REGION, 2020–2028($MILLION)
TABLE 10. DISEASE-ORIENTED BIOBANKING MARKET REVENUE, BY REGION, 2020–2028($MILLION)
TABLE 11. GLOBAL BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028($MILLION)
TABLE 12. BIOBANKING MARKET REVENUE FOR NATIONAL/REGIONAL AGENCY, BY REGION, 2020–2028($MILLION)
TABLE 13. NATIONAL/REGIONAL AGENCY, BY END USER, 2020–2028($MILLION)
TABLE 14. BIOBANKING MARKET REVENUE FOR NON-PROFIT ORGANIZATION, BY REGION, 2020–2028($MILLION)
TABLE 15. NON-PROFIT ORGANIZATION, BY END USER, 2020–2028($MILLION)
TABLE 16. BIOBANKING MARKET REVENUE FOR UNIVERSITY, BY REGION, 2020–2028($MILLION)
TABLE 17. UNIVERSITY, BY END USER, 2020–2028($MILLION)
TABLE 18. BIOBANKING MARKET REVENUE FOR PRIVATE ORGANIZATION, BY REGION, 2020–2028($MILLION)
TABLE 19. PRIVATE ORGANIZATION, BY END USER, 2020–2028($MILLION)
TABLE 20. GLOBAL BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028($MILLION)
TABLE 21. BIOBANKING MARKET REVENUE FOR THERAPEUTIC, BY REGION, 2020–2028($MILLION)
TABLE 22. BIOBANKING MARKET REVENUE FOR RESEARCH, BY REGION, 2020–2028($MILLION)
TABLE 23. GLOBAL BIOBANKING MARKET REVENUE, BY END USER, 2020–2028($MILLION)
TABLE 24. BIOBANKING MARKET REVENUE FOR ACADEMIC INSTITUTIONS, BY REGION, 2020–2028($MILLION)
TABLE 25. BIOBANKING MARKET REVENUE FOR PHARMA & BIOTECH COMPANIES, BY REGION, 2020–2028($MILLION)
TABLE 26. BIOBANKING MARKET REVENUE, BY REGION, 2020–2028 ($MILLION)
TABLE 27. NORTH AMERICA BIOBANKING MARKET REVENUE, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 28. U.S. BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 29. U.S. BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 30. U.S. BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 31. U.S. BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 32. US BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 33. CANADA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 34. CANADA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 35. CANADA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 36. CANADA BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 37. CANADA BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 38. MEXICO BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 39. MEXICO BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 40. MEXICO BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 41. MEXICO BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 42. MEXICO BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 43. NORTH AMERICA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 44. NORTH AMERICA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 45. NORTH AMERICA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 46. NORTH AMERICA BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 47. NORTH AMERICA BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 48. EUROPE BIOBANKING MARKET REVENUE, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 49. GERMANY BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 50. GERMANY BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 51. GERMANY BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 52. GERMANY BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 53. GERMANY BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 54. FRANCE BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 55. FRANCE BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 56. FRANCE BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 57. FRANCE BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 58. FRANCE BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 59. UK BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 60. UK BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 61. UK BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 62. UK BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 63. UK BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 64. ITALY BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 65. ITALY BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 66. ITALY BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 67. ITALY BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 68. ITALY BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 69. SPAIN BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 70. SPAIN BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 71. SPAIN BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 72. SPAIN BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 73. SPAIN BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 74. REST OF EUROPE BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 75. REST OF EUROPE BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 76. REST OF EUROPE BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 77. REST OF EUROPE BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 78. REST OF EUROPE BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 79. EUROPE BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 80. EUROPE BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 81. EUROPE BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 82. EUROPE BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 83. EUROPE BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 84. ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 85. JAPAN BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 86. JAPAN BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 87. JAPAN BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 88. JAPAN BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 89. JAPAN BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 90. CHINA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 91. CHINA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 92. CHINA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 93. CHINA BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 94. CHINA BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 95. INDIA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 96. INDIA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 97. INDIA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 98. INDIA BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 99. INDIA BIOBANKING MARKET REVENUE, BY INDIA, 2020–2028 ($MILLION)
TABLE 100. AUSTRALIA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 101. AUSTRALIA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 102. AUSTRALIA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 103. AUSTRALIA BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 104. AUSTRALIA BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 105. REST OF ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 106. REST OF ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 107. REST OF ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 108. REST OF ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 109. REST OF ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 110. ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 111. ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 112. ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 113. ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 114. ASIA-PACIFIC BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 115. LAMEA BIOBANKING MARKET REVENUE, BY COUNTRY, 2020–2028 ($MILLION)
TABLE 116. BRAZIL BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 117. BRAZIL BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 118. BRAZIL BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 119. BRAZIL BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 120. BRAZIL BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 121. SAUDI ARABIA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 122. SAUDI ARABIA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 123. SAUDI ARABIA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 124. SAUDI ARABIA BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 125. SAUDI ARABIA BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 126. SOUTH AFRICA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 127. SOUTH AFRICA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 128. SOUTH AFRICA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 129. SOUTH AFRICA BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 130. SOUTH AFRICA BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 131. REST OF LAMEA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 132. REST OF LAMEA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 133. REST OF LAMEA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 134. REST OF LAMEA BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 135. REST OF LAMEA BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 136. LAMEA BIOBANKING MARKET REVENUE, BY SPECIMEN TYPE, 2020–2028 ($MILLION)
TABLE 137. LAMEA BIOBANKING MARKET REVENUE, BY TYPE OF BIOBANK, 2020–2028 ($MILLION)
TABLE 138. LAMEA BIOBANKING MARKET REVENUE, BY OWNERSHIP, 2020–2028 ($MILLION)
TABLE 139. LAMEA BIOBANKING MARKET REVENUE, BY APPLICATION, 2020–2028 ($MILLION)
TABLE 140. LAMEA BIOBANKING MARKET REVENUE, BY END USER, 2020–2028 ($MILLION)
TABLE 141. AMSBIO: COMPANY SNAPSHOT
TABLE 142. AMSBIO: PRODUCT CATEGORY
TABLE 143. AMSBIO: PRODUCT PORTFOLIO
TABLE 144. BAY BIOSCIENCES: COMPANY SNAPSHOT
TABLE 145. BAY BIOSCIENCES: PRODUCT CATEGORY
TABLE 146. BAY BIOSCIENCES: PRODUCT PORTFOLIO
TABLE 147. BIOIVT: COMPANY SNAPSHOT
TABLE 148. BIOIVT: OPERATING SEGMENTS
TABLE 149. BIOIVT: PRODUCT PORTFOLIO
TABLE 150. BOCA BIOLISTICS: COMPANY SNAPSHOT
TABLE 151. BOCA BIOLISTICS: OPERATING SEGMENTS
TABLE 152. BOCA BIOLISTICS: PRODUCT PORTFOLIO
TABLE 153. CTI BIOTECH: COMPANY SNAPSHOT
TABLE 154. CTI BIOTECH: OPERATING SEGMENTS
TABLE 155. CTI BIOTECH: SERVICE PORTFOLIO
TABLE 156. CURELINE: COMPANY SNAPSHOT
TABLE 157. CURELINE: OPERATING SEGMENTS
TABLE 158. CURELINE: SERVICE PORTFOLIO
TABLE 159. FIRALIS: COMPANY SNAPSHOT
TABLE 160. FIRALIS: OPERATING SEGMENTS
TABLE 161. FIRALIS: SERVICE PORTFOLIO
TABLE 162. GENETICIST: COMPANY SNAPSHOT
TABLE 163. GENETICIST COMPANY: SEGMENTS
TABLE 164. GENETICIST: PRODUCT PORTFOLIO
TABLE 165. PROTEOGENEX: COMPANY SNAPSHOT
TABLE 166. PROTEOGENEX: OPERATING SEGMENTS
TABLE 167. PROTEOGENEX: PRODUCT PORTFOLIO
TABLE 168. US BIOLAB: COMPANY SNAPSHOT
TABLE 169. US BIOLAB: OPERATING SEGMENTS
TABLE 170. US BIOLAB: PRODUCT PORTFOLIO
List of Figures
FIGURE 01. GLOBAL BIOBANKING MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06. MODERATE BARGAINING POWER OF BUYERS
FIGURE 07. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08. HIGH THREAT OF NEW ENTRANTS
FIGURE 09. MODERATE THREAT OF SUBSTITUTION
FIGURE 10. MODERATE COMPETITIVE RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. DRIVERS, RESTRAINTS, AND OPPORTUNITY
FIGURE 13. BIOBANKING MARKET REVENUE FOR BLOOD PRODUCTS, BY COUNTRY, 2020–2028(%)
FIGURE 14. BIOBANKING MARKET REVENUE FOR SOLID TISSUE, BY COUNTRY, 2020–2028(%)
FIGURE 15. BIOBANKING MARKET REVENUE FOR CELL LINES, BY COUNTRY, 2020–2028(%)
FIGURE 16. BIOBANKING MARKET REVENUE FOR NUCLEIC ACID SAMPLES, BY COUNTRY, 2020–2028(%)
FIGURE 17. BIOBANKING MARKET REVENUE FOR OTHERS, BY COUNTRY, 2020–2028(%)
FIGURE 18. POPULATION-BASED BIOBANKING MARKET REVENUE, BY COUNTRY, 2020–2028(%)
FIGURE 19. DISEASE-ORIENTED BIOBANKING REVENUE, BY COUNTRY, 2020–2028(%)
FIGURE 20. BIOBANKING MARKET REVENUE FOR NATIONAL/REGIONAL AGENCY, BY COUNTRY, 2020–2028(%)
FIGURE 21. BIOBANKING MARKET REVENUE FOR NON-PROFIT ORGANIZATION, BY COUNTRY, 2020–2028(%)
FIGURE 22. BIOBANKING MARKET REVENUE FOR UNIVERSITY, BY COUNTRY, 2020–2028(%)
FIGURE 23. BIOBANKING MARKET REVENUE FOR PRIVATE ORGANIZATION, BY COUNTRY, 2020–2028(%)
FIGURE 24. BIOBANKING MARKET REVENUE FOR THERAPEUTIC, BY COUNTRY, 2020–2028(%)
FIGURE 25. BIOBANKING MARKET REVENUE FOR RESEARCH, BY COUNTRY, 2020–2028(%)
FIGURE 26. BIOBANKING MARKET REVENUE FOR ACADEMIC INSTITUTIONS, BY COUNTRY, 2020–2028(%)
FIGURE 27. BIOBANKING MARKET REVENUE FOR PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2020–2028(%)